Johnson & Johnson and Bayer’s Xarelto, once king of the warfarin alternative market, is now chasing chasing Pfizer and Bristol-Myers Squibb’s Eliquis. But with a new approved indication in the books—its eighth—it’s not backing down. The FDA on Monday approved Xarelto to help prevent blood clots for acutely ill patients without a high risk of bleeding during… Read More »
At 30, Amanda Johnson learned that she had about 16 months to live after her on-again-off-again headaches lead to a glioblastoma diagnosis. In fact, the tumor in her brain was so large that it was threatening even the short time frame that she was given. Amanda Johnson, pictured with dad Larry, started getting headaches, which… Read More »
Digital pharmacy GoodRx is now helping patients do more than just price shop for prescription drugs, co-founder and co-CEO Doug Hirsch told CNBC’s Jim Cramer on Friday. It’s going directly into the world of medical services by launching GoodRx Care, which allows people to see a board-certified physician for a number of conditions, starting at… Read More »
FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Print this page NEWTON, Mass., July 03, 2019 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved oral Xpovio (selinexor), a nuclear export inhibitor, in combination… Read More »